Live with ASHP: Spotlight on Science: The Weight Debate — Best Practices for High-Risk Medication Dosing Controversies in Extreme Weight Patients
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Live with ASHP: Spotlight on Science: The Weight Debate — Best Practices for High-Risk Medication Dosing Controversies in Extreme Weight Patients
-
Lu par :
-
De :
À propos de ce contenu audio
A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !